ARTL
Artelo Biosciences Inc
NASDAQ: ARTL · HEALTHCARE · BIOTECHNOLOGY
$3.49
+2.35% today
Updated 2026-04-30
Market cap
$3.79M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-37.56
Dividend yield
—
52W range
$3 – $86
Volume
4.2M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$18.00
+415.76%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-2.92M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-10.08M | $-9.29M | $-9.83M | $-12.88M | $-4.17M |
| EPS | — | — | — | — | $-37.56 |
| Free cash flow | $-8.01M | $-8.21M | $-8.35M | $-8.52M | $-2.92M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Artelo Biosciences Inc trades at $3.49. Our Smart Value Score of 26/100 indicates the stock is weak.
Frequently asked questions
What is Artelo Biosciences Inc's stock price?
Artelo Biosciences Inc (ARTL) trades at $3.49.
Is Artelo Biosciences Inc overvalued?
Smart Value Score 26/100 (Grade F, Strong Sell).
What is the price target of Artelo Biosciences Inc (ARTL)?
The analyst target price is $18.00, representing +415.8% upside from the current price of $3.49.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-1,625.00%
Beta0.41
50D MA$5.04
200D MA$12.96
Shares out0.00B
Float0.00B
Short ratio—
Avg volume4.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—